Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126470051 | 12647005 | 1 | I | 20160725 | 20160812 | 20160812 | EXP | CA-MLMSERVICE-20160726-0367439-1 | CA-ACCORD-043057 | ACCORD | DI PALMA?A, SEBAJANG?H, SCHWENTER?F. METASTATIC RECTAL NEUROENDOCRINE TUMOR PRESENTING AS AN INGUINAL MASS: A CASE REPORT AND REVIEW OF LITERATURE. INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS. 2016; 26:27-29. | 52.00 | YR | M | Y | 0.00000 | 20160812 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126470051 | 12647005 | 1 | PS | ETOPOSIDE. | ETOPOSIDE | 1 | 6 CYCLES | 74513 | |||||||||||
| 126470051 | 12647005 | 2 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | 6 CYCLES | 200750028 | |||||||||||
| 126470051 | 12647005 | 3 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | 11 CYCLES | 40743 | |||||||||||
| 126470051 | 12647005 | 4 | SS | IRINOTECAN | IRINOTECAN | 1 | 11 CYCLES | 79068 | |||||||||||
| 126470051 | 12647005 | 5 | C | TOPOTECAN | TOPOTECANTOPOTECAN HYDROCHLORIDE | 1 | 2 CYCLES | 0 | |||||||||||
| 126470051 | 12647005 | 6 | SS | FOLINIC ACID | LEUCOVORIN | 1 | 11 CYCLES | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126470051 | 12647005 | 1 | Neuroendocrine carcinoma metastatic |
| 126470051 | 12647005 | 2 | Neuroendocrine carcinoma metastatic |
| 126470051 | 12647005 | 3 | Neuroendocrine carcinoma metastatic |
| 126470051 | 12647005 | 4 | Neuroendocrine carcinoma metastatic |
| 126470051 | 12647005 | 5 | Neuroendocrine carcinoma metastatic |
| 126470051 | 12647005 | 6 | Neuroendocrine carcinoma metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126470051 | 12647005 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126470051 | 12647005 | Hepatotoxicity | |
| 126470051 | 12647005 | Neutropenia | |
| 126470051 | 12647005 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |